20,

Helen M Parsons1, Todd M Tuttle, Karen M Kuntz

  • 1Applied Research Program, National Cancer Institute, Executive Plaza North, 6130 Executive Blvd, MSC 7344, Bethesda, MD 20892-7344, USA. helen.parsons@nih.gov

JAMA
|September 16, 2011
PubMed
概括

在结肠癌手术中更多的淋巴结评估可以提高生存率,但不是通过增加癌症阶段. 这表明其他机制正在发挥作用,以改善患者的治疗结果.